4 medtech notes: Saluda Medica, VySpine and more

Here are four updates in orthopedic and spine medtech since Jan. 11:

Advertisement

1. The American Medical Association issued a CPT add-on code for the second level in lumbar total disc procedures.

2. A long-term study of Saluda Medical’s Evoke spinal cord stimulator found most patients had significant pain reduction and no explants.

3. VySpine’s LumiVy NanoVy Ti lumbar interbody fusion system earned FDA clearance.

4. Lipogems enrolled the first patient in a U.S. study focusing on MicroFat injections in knee osteoarthritis.

 

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Is ambulatory care healthcare’s big margin engine? 4 leaders weigh in

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: Joe Ganley, athenahealthJeffrey Flynn, CASC, Gramercy Surgery CenterBryan Tsao, Access Center, Loma Linda University HealthJason Zepeda, Northridge Hospital Medical Center, CommonSpirit HealthGreg DeConciliis, PA-C, CASC, Boston Out­Patient Surgical Suites

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.